Meu medo é ter que voltar a ver aquele dancinha do “ela tá tá movimentando, tá tá movimentando” 😰😰😰 Referências: Voleti N, et al. Myocarditis in SARS-CoV-2 infection vs. COVID-19 vaccination: A systematic review and meta-analysis. Front Cardiovasc Med. 2022;9:951314. https://doi.org/10.3389/fcvm.2022.951314 Pekar JE, et al. The molecular epidemiology of multiple zoonotic origins of SARS-CoV-2. Science. 2022;377(6609):960-966. https://doi.org/10.1126/science.abp8337 WHO Solidarity Trial Consortium, et al. Repurposed Antiviral Drugs for Covid-19 – Interim WHO Solidarity Trial Results. N Engl J Med. 2021;384(6):497-511. https://doi.org/10.1056/NEJMoa2023184 Talic S, et al. Effectiveness of public health measures in reducing the incidence of COVID-19, SARS-CoV-2 transmission, and COVID-19 mortality: systematic review and meta-analysis. BMJ. 2021;375:e068302. https://doi.org/10.1136/bmj-2021-068302 Mendez-Brito A, et al. Systematic review of empirical studies comparing the effectiveness of non-pharmaceutical interventions against COVID-19. J Infect. 2021;83(3):281-293. https://doi.org/10.1016/j.jinf.2021.06.018 Feikin DR, et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet. 2022;399(10328):924-944. https://doi.org/10.1016/S0140-6736(22)00152-0 Polack FP, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020;383(27):2603-2615. https://doi.org/10.1056/NEJMoa2034577 FDA. FDA approves required updated warning in labeling of mRNA COVID-19 vaccines regarding myocarditis and pericarditis following vaccination. 2025. Disponível em: https://www.fda.gov/vaccines-blood-biologics/safety-availability-biologics/fda-approves-required-updated-warning-labeling-mrna-covid-19-vaccines-regarding-myocarditis-and World Health Organization (WHO). Independent assessment of the origins of SARS-CoV-2. Geneva: WHO; 2025. Disponível em: https://www.who.int/publications/m/item/independent-assessment-of-the-origins-of-sars-cov-2-from-the-scientific-advisory-group-for-the-origins-of-novel-pathogens
22.42% ERengagement of this clip — above the author's average (3.37%)
top 70%outperforms 30% of the author's clips
7%of the author's average views
